Royal Society of Chemistry, Dalton Transactions, 45(49), p. 16425-16439, 2020
DOI: 10.1039/d0dt01389g
Full text: Unavailable
l-Phenylalanine (l-Phe) was used as a ligand model for the anticancer drug melphalan. CoIII–Phe complexes were successfully designed for hypoxia-selective release of l-Phe from CoIII–Phe upon Co3+/Co2+ reduction by ascorbic acid.